by Ian Lipman | Sep 16, 2022 | News
Client News Roquefort Therapeutics plc: Investor Presentation Home / Client News / Roquefort Therapeutics plc: Investor Presentation Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class drugs in the...
by Ian Lipman | Sep 16, 2022 | News
Client News Roquefort Therapeutics plc: Board and Management Appointments Home / Client News / Roquefort Therapeutics plc: Board and Management Appointments Roquefort Therapeutics (LSE:ROQ,OTCQB:ROQAF), the Main Market listed biotech company focused on developing...
by Ian Lipman | Sep 16, 2022 | News
Client News Roquefort Therapeutics PLC: Acquisition Completion, Admission & Voting Rights Home / Client News / Roquefort Therapeutics PLC: Acquisition Completion, Admission & Voting Rights Roquefort Therapeutics (LSE:ROQ,OTCQB:ROQAF), the Main Market listed...
by Ian Lipman | Sep 15, 2022 | News
Client News Predator Oil & Gas Holdings Plc: AGM Resolutions Home / Client News / Predator Oil & Gas Holdings Plc: AGM Resolutions At the Annual General Meeting of Predator Oil & Gas Holdings Plc (PRD), held earlier today, all resolutions were duly...
by Ian Lipman | Sep 15, 2022 | News
Client News Roquefort Therapeutics plc: Notice of Admission Home / Client News / Roquefort Therapeutics plc: Notice of Admission Roquefort Therapeutics (LSE:ROQ,OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class drugs in the high...
Recent Comments